1. Targeting ATR in cancer
   Emilio Lecona et al, 2018, Nature Reviews Cancer CrossRef
2. ATR Inhibition in Advanced Urothelial Carcinoma
   Ryan C. Leibrandt et al, 2023, Clinical Genitourinary Cancer CrossRef
3. ATM Inhibitor Suppresses Gemcitabine-Resistant BTC Growth in a Polymerase θ Deficiency-Dependent Manner
   Yi-Ru Pan et al, 2020, Biomolecules CrossRef
4. The ATR Inhibitor AZD6738 Synergizes with Gemcitabine In Vitro and In Vivo to Induce Pancreatic Ductal Adenocarcinoma Regression
   Yann Wallez et al, 2018, Molecular Cancer Therapeutics CrossRef
5. DNA damage checkpoint kinases in cancer
   Hannah L. Smith et al, 2020, Expert Reviews in Molecular Medicine CrossRef
6. Synergistic anticancer activity of combined ATR and ribonucleotide reductase inhibition in Ewing's sarcoma cells
   Max-Johann Sturm et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
7. Effects of CXCL12 isoforms in a pancreatic pre-tumour cellular model: Microarray analysis
   Monia Cecati et al, 2021, World Journal of Gastroenterology CrossRef
8. DNA damage response revisited: the p53 family and its regulators provide endless cancer therapy opportunities
   Yasser Abuetabh et al, 2022, Experimental & Molecular Medicine CrossRef
9. Inhibition of ATR acutely sensitizes acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductase
   Sarah E. Fordham et al, 2018, Blood Advances CrossRef
10. A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer
    Panagiotis A. Konstantinopoulos et al, 2021, Nature Communications CrossRef
11. Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial
    Panagiotis A Konstantinopoulos et al, 2020, The Lancet Oncology CrossRef
12. Key Proteins of Replication Stress Response and Cell Cycle Control as Cancer Therapy Targets
    Alvina I. Khamidullina et al, 2024, International Journal of Molecular Sciences CrossRef
13. Exploiting DNA Replication Stress for Cancer Treatment
    Tajinder Ubhi et al, 2019, Cancer Research CrossRef
14. Therapeutic resistance of pancreatic cancer: Roadmap to its reversal
    Sen Yu et al, 2021, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
15. Targeting replication stress in cancer therapy
    Alexandre André B. A. da Costa et al, 2023, Nature Reviews Drug Discovery CrossRef
16. Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma
    Sumanta K. Pal et al, 2021, JAMA Oncology CrossRef
17. Inhibition of Wee1 sensitizes AML cells to ATR inhibitor VE-822-induced DNA damage and apoptosis
    Wenxiu Qi et al, 2019, Biochemical Pharmacology CrossRef
18. Fisetin inhibits proliferation of pancreatic adenocarcinoma by inducing DNA damage via RFXAP/KDM4A-dependent histone H3K36 demethylation
    Guoping Ding et al, 2020, Cell Death & Disease CrossRef
19. Glutamine deprivation counteracts hypoxia-induced chemoresistance
    Jessica Wappler et al, 2020, Neoplasia CrossRef
20. Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker Analyses
    Panagiotis A. Konstantinopoulos et al, 2024, JCO Precision Oncology CrossRef